135 related articles for article (PubMed ID: 6547348)
1. Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy.
Viganò S; Mannucci PM; Solinas S; Bottasso B; Mariani G
Br J Haematol; 1984 Jun; 57(2):213-20. PubMed ID: 6547348
[TBL] [Abstract][Full Text] [Related]
2. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
3. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
Thompson AR
J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
[TBL] [Abstract][Full Text] [Related]
4. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy.
Takahashi H; Hanano M; Hayashi S; Arai Y; Yoshino N; Takakuwa E; Tatewaki W; Nagayama R; Takizawa S; Shibata A
Tohoku J Exp Med; 1986 Aug; 149(4):351-7. PubMed ID: 3775760
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy.
Forestier F; Daffos F; Rainaut M; Solé Y; Amiral J
Thromb Haemost; 1985 Jun; 53(3):401-3. PubMed ID: 3840288
[TBL] [Abstract][Full Text] [Related]
7. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
Xi M; Béguin S; Hemker HC
Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
[TBL] [Abstract][Full Text] [Related]
8. A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin.
Bajaj SP; Rapaport SI; Maki SL; Brown SF
Prep Biochem; 1983; 13(3):191-214. PubMed ID: 6226944
[TBL] [Abstract][Full Text] [Related]
9. Protein C, factor VII and prothrombin time as early markers of liver function recovery or failure after liver transplantation.
Patrassi GM; Sartori MT; Viero M; Boeri G; Simioni P; Bassi N; Piccinni P; Girolami A
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):863-7. PubMed ID: 8148479
[TBL] [Abstract][Full Text] [Related]
10. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
[TBL] [Abstract][Full Text] [Related]
11. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays.
Poort SR; van der Linden IK; Krommenhoek-van Es C; Briët E; Bertina RM
Thromb Haemost; 1986 Feb; 55(1):122-8. PubMed ID: 3704999
[TBL] [Abstract][Full Text] [Related]
12. Influence of warfarin therapy on activated factor VII clotting activity.
Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
[TBL] [Abstract][Full Text] [Related]
13. A true hypercoagulability state in patients on chronic hemodialysis.
Erickson RV; Williman M; Pendras JP
Trans Am Soc Artif Intern Organs; 1966; 12():205-6. PubMed ID: 5960704
[No Abstract] [Full Text] [Related]
14. Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy.
Weiss P; Soff GA; Halkin H; Seligsohn U
Thromb Res; 1987 Mar; 45(6):783-90. PubMed ID: 2954263
[TBL] [Abstract][Full Text] [Related]
15. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
17. [Production of various vitamin K-dependent coagulation factors by immunoadsorbent technics and their clinical application].
Takamiya O
Rinsho Byori; 1985 Feb; Spec No 61():119-23. PubMed ID: 3889420
[No Abstract] [Full Text] [Related]
18. Factor II, VII, IX and X concentrations in patients receiving long term warfarin.
Paul B; Oxley A; Brigham K; Cox T; Hamilton PJ
J Clin Pathol; 1987 Jan; 40(1):94-8. PubMed ID: 3818977
[TBL] [Abstract][Full Text] [Related]
19. Protein C response to induction of warfarin treatment after coronary bypass operation.
Iguchi A; Sato K
Thorac Cardiovasc Surg; 1994 Aug; 42(4):222-4. PubMed ID: 7825160
[TBL] [Abstract][Full Text] [Related]
20. Protein C level at birth.
Polack B; Pouzol P; Amiral J; Kolodie L
Thromb Haemost; 1984 Oct; 52(2):188-91. PubMed ID: 6549231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
